Pharmaceuticals, Biotechnology and Life Sciences
New analyses of the VOYAGE 1 Phase 3 head-to-head data show a higher proportion of patients treated with guselkumab reported…
CAMBRIDGE, England–(BUSINESS WIRE)–FOR MEDICAL BUSINESS/TRADE MEDIA ONLY Mundipharma announced today that Marc Princen has joined the Mundipharma network of independently…
Company announces strategic collaboration with SR-Tiget MILAN–(BUSINESS WIRE)–#investing—Epsilen Bio, a biotechnology company developing transformative therapies for patients affected by underserved…
Data from a Phase II trial show a regimen of Truxima® (biosimilar rituximab), lenalidomide and acalabrutinib (R2A) was well tolerated…
NEW YORK–(BUSINESS WIRE)–IVERIC bio, Inc. (Nasdaq: ISEE) today announced that it will report 18 month data from the Zimura® (avacincaptad…
ROCKVILLE, Md.–(BUSINESS WIRE)–OncoImmune, Inc. reached an important milestone in its Phase III clinical trial testing the safety and clinical efficacy…
BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. ( “Sinovac” or the “ Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today…
Post-hoc closed testing analysis suggests onset of a migraine preventive effect with intravenous VYEPTI as early as day 1 following…
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together…
ANDROMEDA study investigated the first and only subcutaneous anti-CD38 monoclonal antibody in treatment of rare multi-system disease with a high…